|
AP21568b-ev
|
Abcepta, Inc.
|
TRRAP [C-term] [RB51386], Rabbit Polyclonal Antibody
|
Human
|
WB, IF
|
|
|
AP21568b
|
Abcepta, Inc.
|
TRRAP [C-term] [RB51386], Rabbit Polyclonal Antibody
|
Human
|
WB, IF
|
|
|
ATGA0476-100ul
|
NKMax Bio (ATGen)
|
Dkk-3 [AT103B5], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
ATGA0476-50ul
|
NKMax Bio (ATGen)
|
Dkk-3 [AT103B5], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
ATGP1699-250ug
|
NKMax Bio (ATGen)
|
CSNK2A2 [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP1699-50ug
|
NKMax Bio (ATGen)
|
CSNK2A2 [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP1666-100ug
|
NKMax Bio (ATGen)
|
Dkk-3 [22-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
ATGP1666-500ug
|
NKMax Bio (ATGen)
|
Dkk-3 [22-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
ATGP3520-100ug
|
NKMax Bio (ATGen)
|
Dkk-3 [22-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3520-20ug
|
NKMax Bio (ATGen)
|
Dkk-3 [22-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP2056-10ug
|
NKMax Bio (ATGen)
|
mutY [1-350 a.a.], Recombinant Protein
|
E.coli
|
SDS-PAGE
|
|
|
ATGP2056-50ug
|
NKMax Bio (ATGen)
|
mutY [1-350 a.a.], Recombinant Protein
|
E.coli
|
SDS-PAGE
|
|
|
ATGP2465-100ug
|
NKMax Bio (ATGen)
|
RAD51B [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
ATGP2465-500ug
|
NKMax Bio (ATGen)
|
RAD51B [1-350 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE, Denatured
|
|
|
GTX100212
|
GeneTex International Corporation
|
CENPF [C3], C-term, Rabbit Polyclonal Antibody
|
Human, Zebrafish
|
ICC/IF, IHC-P, WB, IHC-Wm
|
|
|
GTX100212-S
|
GeneTex International Corporation
|
CENPF [C3], C-term, Rabbit Polyclonal Antibody
|
Human, Zebrafish
|
ICC/IF, IHC-P, WB, IHC-Wm
|
|
|
228-12801-2
|
RayBiotech, Inc.
|
GRB2-Related Adaptor Protein 2, Human Recombinant
|
|
|
|
|
HY-138831-10mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138831-100mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138831-25mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138831-5mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
|
HY-138831-50mg
|
MedChemexpress LLC
|
AES-350 [CAS 847249-57-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10237-10mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
|
HY-10237-100mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
|
HY-10237-200mg
|
MedChemexpress LLC
|
Boceprevir [CAS 394730-60-0]
|
|
COVID-19-anti-virus
|
|
